2024 - NCI-CONNECTions
-
Donita’s friends and family helped create a recovery plan, cook meals, and care for her after she underwent surgery to remove her pilocytic astrocytoma.
-
An interim study analysis demonstrates that combining Fitbit data with self-assessments is a reliable method for understanding sleep changes in patients.
-
A phase 1/2 clinical trial is testing an investigational drug called PLX038 on hard-to-treat central nervous system tumors containing extra copies of the MYC and MYCN genes.
-
A data analysis shows the value of the @NIHBrainTumor X (formerly Twitter) account as a resource for patients, caregivers, and advocates, as well as neuro-oncology providers and researchers.
-
Mikaeel shares how returning to work kept him focused and optimistic throughout treatment for his oligodendroglioma.
-
A new study explores how non-medical factors influence the neurocognitive and mood-related symptoms that people with brain tumors experience. These factors include gender or sex, education, where people live, and more.
-
The new analyses reveal critical information that will help providers and researchers understand the unique needs of these patients.
-
NCI-CONNECT raised awareness for ependymoma and honored patients, care partners, and medical professionals in a butterfly release event at NIH.
-
Outcomes Program Manager Alvina Acquaye-Mallory answers questions about how health care providers, patients, and caregivers can cope with stress and burnout during their cancer care journey.
-
This May, share information about brain and spine tumors to raise awareness, educate the community, and help people living with these cancers.